Haixiang Pharmaceutical: The affiliated company Huayi Taikang's application for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange has been accepted

Haixiang Pharmaceutical announced that the application by Huayi Taikang Pharmaceutical Co., Ltd., in which the company holds an equity stake, for a public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange has been accepted by the Beijing Stock Exchange. Huayi Taikang received the “Acceptance Notice” issued by the Beijing Stock Exchange on March 31, 2026. As of the date of the announcement, Haixiang Pharmaceutical holds 1.11M shares of Huayi Taikang, accounting for 1.85% of its total shares. Huayi Taikang’s listing application still requires approval from the Beijing Stock Exchange and registration approval from the China Securities Regulatory Commission, and the final outcome is uncertain.